Launch of [KIPRES Tablet], Leukotriene Receptor Antagonist/Bronchial Asthma Treatment Medicine in Japan
August 31, 2001
Kyorin Pharmaceutical Co., Ltd. (President: Ikuo Ogihara, Head Office: Tokyo) has launched the leukotriene receptor antagonist/ bronchial asthma treatment medicine Kipres Tablet 10 and Kipres Chewable Tablet 5 in Japan .
Recently, leukotriene (a chemical mediator), which is strongly related to inflammation of the bronchial airway, has been the focus of our attention. Merck & Co., Inc originally developed KIPRES tablets, which are leukotriene receptor antagonists that are selective to CysLT1.
- Launch of [KIPRES Tablet], Leukotriene Receptor Antagonist/Bronchial Asthma Treatment Medicine in Japan [ PDF 8.2 KB ]
Adobe Reader software is required to view and print PDF files. The latest version of Adobe Reader can be downloaded by accessing the Adobe Systems Incorporated website.